Literature DB >> 15193673

Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Richard E Waters1, Kanwar P Singh, Matthew T Roe, Mat Lotfi, Michael H Sketch, Kenneth W Mahaffey, L Kristin Newby, John H Alexander, Robert A Harrington, Robert M Califf, Christopher B Granger.   

Abstract

The focus for the initial approach to the treatment of acute ST-segment elevation myocardial infarction (STEMI) has shifted toward extending the benefits of mechanical reperfusion with primary percutaneous coronary intervention (PCI) to patients who present to community hospitals that have no interventional capabilities. Several randomized clinical trials have shown that transferring STEMI patients to tertiary centers for primary PCI leads to better outcomes than when fibrinolytic therapy is administered at community hospitals. Furthermore, potent pharmacologic reperfusion regimens that enhance early reperfusion of the infarct vessel before primary PCI may enhance the positive result of the transfer approach. Despite these promising findings, several obstacles have hindered the adoption of patient-transfer strategies in the U.S., including greater distances between community and tertiary hospitals, a lack of integrated emergency medical services, and the medical community's limited experience with centralized acute myocardial infarction (AMI) care networks. Nonetheless, the implementation of system-wide changes in the care of STEMI patients analogous to the creation of trauma networks could facilitate the creation and ongoing evaluation of dedicated patient transfer strategies and better early invasive care in the U.S. Within this context, a systematic, stepwise approach to the creation of AMI care networks and to the development of standard nomenclature and performance indicators is necessary to guide quality assurance monitoring and future research efforts as the care of STEMI patients is redefined. Consequently, this current evolution of reperfusion strategies has the potential to further reduce morbidity and mortality for patients presenting with STEMI.

Entities:  

Mesh:

Year:  2004        PMID: 15193673     DOI: 10.1016/j.jacc.2003.12.057

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study.

Authors:  Thao Huynh; Jennifer O'Loughlin; Lawrence Joseph; Erick Schampaert; Stéphane Rinfret; Marc Afilalo; Simon Kouz; Bernard Cantin; Michel Nguyen; Mark J Eisenberg
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

Review 2.  The History of Primary Angioplasty and Stenting for Acute Myocardial Infarction.

Authors:  Nathaniel R Smilowitz; Frederick Feit
Journal:  Curr Cardiol Rep       Date:  2016-01       Impact factor: 2.931

3.  Quality measure study: progress in reducing the door-to-balloon time in patients with ST-segment elevation myocardial infarction.

Authors:  Katsufumi Nishida; Sean K Hirota; Todd B Seto; Daniel C Smith; Cathy Young; Wanda Muranaka; Suzanne Beauvallet; David Fergusson
Journal:  Hawaii Med J       Date:  2010-10

4.  Frequency and safety of switching antithrombin therapy at a regional PCI center.

Authors:  Bina Ahmed; Colleen Thomas; Carl Kapadia; Faraz Sandhu; Sadie Mills; Faye Straight; David J Schneider; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

5.  Expedited transfer for primary percutaneous coronary intervention: a program evaluation.

Authors:  Jacobus S de Villiers; Todd Anderson; James D McMeekin; Raymond C M Leung; Mouhieddin Traboulsi
Journal:  CMAJ       Date:  2007-06-19       Impact factor: 8.262

6.  Society of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) Criteria: A 7M Management Approach to Developing a Stroke Interventional Laboratory in the Era of Stroke Thrombectomy for Large Vessel Occlusions.

Authors:  Tanzila Shams; Osama Zaidat; Dileep Yavagal; Andrew Xavier; Tudor Jovin; Vallabh Janardhan
Journal:  Interv Neurol       Date:  2016-02-26

Review 7.  Acute ischemic heart disease and interventional cardiology: a time for pause.

Authors:  Peter Bogaty; James M Brophy
Journal:  BMC Med       Date:  2006-10-11       Impact factor: 8.775

8.  Population access to reperfusion services for ST-segment elevation myocardial infarction in Kerala, India.

Authors:  Anoop Mathew; Jabir Abdullakutty; Placid Sebastian; Sunitha Viswanathan; Cibu Mathew; Venugopalan Nair; Padinhare P Mohanan; A George Koshy
Journal:  Indian Heart J       Date:  2017-03-06

9.  Clinical Profile and Mortality of ST-Segment Elevation Myocardial Infarction Patients Receiving Thrombolytic Therapy in the Middle East.

Authors:  Prashanth Panduranga; Ibrahim Al-Zakwani; Kadhim Sulaiman; Khalid Al-Habib; Jassim Al Suwaidi; Ahmed Al-Motarreb; Alawi Alsheikh-Ali; Shukri Al Saif; Hussam Al Faleh; Wael Almahmeed; Nidal Asaad; Haitham Amin; Jawad Al-Lawati; Ahmad Hersi
Journal:  Heart Views       Date:  2012-04

10.  One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors.

Authors:  Thomas M Maddox; Kimberly J Reid; John S Rumsfeld; John A Spertus
Journal:  BMC Cardiovasc Disord       Date:  2007-09-12       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.